Mortsel, Belgium – December 13, 2021 – 5:40 p.m. CET Info
Inside the structure of the offer buyback program which was reported in the official statement of March 10, 2021, Agfa-Gevaert NV continued with the acquisition of own portions available of Euronext Brussels.
The approval to get own portions was conceded to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.
Agfa-Gevaert NV has mentioned a monetary mediator to repurchase Agfa-Gevaert shares for a greatest measure of 50,000,000 Euro for its benefit under the details of an underlying optional order concurrence with legitimacy until March 31, 2022, viable as from April 1, 2021.
Because of a choice of the Board of Directors, the organization, by notarial deed dated September 27, 2021, dropped a sum of 2,959,298 depository shares. This choice was taken as per the approval conceded to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020. As an outcome, the new number of remarkable offers (denominator) is 162,795,008.
On December 10, 2021, the Agfa-Gevaert Group held 1,843,456 own portions, which addresses 1.13% of the absolute number of portions of the Group.
Detailed operations per day:
|Date||Number of shares||Average
|December 6, 2021||50,000||3.5690||3.5150||3.6050||178,450.00|
|December 7, 2021||44,649||3.6589||3.6050||3.6850||163,366.23|
|December 8, 2021||50,000||3.6829||3.6300||3.7150||184,145.00|
|December 9, 2021||50,000||3.6044||3.5550||3.6800||180,220.00|
Since the beginning of the share buyback program until December 10th, 2021; the Agfa-Gevaert Group bought 6,799,638 own shares, representing 4.05% of the total outstanding shares on April 1, 2021.
About Agfa 2021
The Agfa-Gevaert Group is a main organization in imaging innovation and IT arrangements with more than 150 years of involvement. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print and Chemicals and Offset Solutions. They create, production and market simple and advanced frameworks for the medical services area, for explicit modern applications and for the printing business. In 2020, the Group understood a turnover of 1,709 million Euro.
Director Corporate Communication
T +32 (0) 3 444 71 24
E [email protected]
Corporate Press Relations Manager
T +32 (0)3/444 80 15
E [email protected]
Source link: https://www.globenewswire.com/